TiterVac 5

Manufacturer: Aspen

Bovine Rhinotracheitis-virus Diarrhea-parainfluenza₃-respiratory Syncytial Virus Vaccine

Modified Live Virus

Ibr-bvdi-bvdii-pi₃-brsv

TiterVac 5 Indications

This product contains BVD Type I and BVD Type II and is recommended for the vaccination of healthy cattle as an aid in the prevention of disease caused by infectious bovine rhinotracheitis virus (IBR), bovine virus diarrhea virus, Type l (BVD), bovine virus diarrhea virus, Type ll (BVD), bovine parainfluenza₃ virus (PI₃), and bovine respiratory syncytial virus (BRSV).

Directions And Dosage

Rehydrate the desiccated vial with accompanying diluent and shake well. Inject 2 mL subcutaneously or intramuscularly using aseptic technique, followed by a second dose of monovalent bovine respiratory syncytial virus vaccine (TiterVac^® BRSV) to be given 14 to 28 days after the first dose. Annual revaccination is recommended. Calves vaccinated before weaning should be revaccinated 30 days after weaning when the possible influence of maternal antibodies is decreased.

TiterVac 5 Caution

Store at 35° to 45° F (2° to 7° C). DO NOT FREEZE. Use entire contents when first rehydrated. Allergic reactions may follow the use of vaccines.

Antidote

Epinephrine. Do not vaccinate within 21 days before slaughter. Burn container and all unused contents.

Do Not Use In Pregnant Cows Or In Calves Nursing Pregnant Cows. Abortions May Result.

For Use In Animals Only

Manufactured by: Diamond Animal Health, Inc., Des Moines, Iowa 50327 USA

US Veterinary License No. 213

Distributed by: Aspen Veterinary Resources,^® Ltd., Liberty, MO 64068 USA

TiterVac is a registered trademark of Aspen Veterinary Resources,^® Ltd.

10 Doses	20 mL	010098, 03441
50 Doses	100 mL	010099

Nac No.

14751720